title: Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.
authors.affiliation: University of California, San Francisco, CA.
authors.forename: Prescott G
authors.initials: PG
authors.lastname: Woodruff
authors.forename: Wissam
authors.initials: W
authors.lastname: Chatila
authors.forename: John E
authors.initials: JE
authors.lastname: Connett
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Criner
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Curtis
authors.forename: Mark T
authors.initials: MT
authors.lastname: Dransfield
authors.forename: Meilan K
authors.initials: MK
authors.lastname: Han
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Lazarus
authors.forename: Nathaniel
authors.initials: N
authors.lastname: Marchetti
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Rogers
authors.forename: Paul D
authors.initials: PD
authors.lastname: Scanlon
authors.forename: Don D
authors.initials: DD
authors.lastname: Sin
authors.forename: Helen
authors.initials: H
authors.lastname: Voelker
authors.forename: Christine
authors.initials: C
authors.lastname: Wendt
authors.forename: Richard K
authors.initials: RK
authors.lastname: Albert
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D016016:Proportional Hazards Models; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000378:metabolism*; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D047889:Receptors, Tumor Necrosis Factor, Type II; C415902:TNFRSF1B protein, human; D017963:Azithromycin